Mouse (115 sources):
abnormal T-helper 1 physiology,
abnormal adaptive immunity,
abnormal adrenocorticotropin level,
abnormal blood coagulation,
abnormal blood homeostasis,
abnormal bone healing,
abnormal bone mineralization,
abnormal brain wave pattern,
abnormal circadian sleep/wake cycle,
abnormal circulating estradiol level,
abnormal digestion,
abnormal enzyme/coenzyme level,
abnormal eosinophil cell number,
abnormal frequency of paradoxical sleep,
abnormal gametogenesis,
abnormal glycogen homeostasis,
abnormal heart right ventricle pressure,
abnormal hormone level,
abnormal induced retina neovascularization,
abnormal involution of the mammary gland,
abnormal kidney morphology,
abnormal macrophage physiology,
abnormal male meiosis,
abnormal mammary gland physiology,
abnormal motor capabilities/coordination/movement,
abnormal myocardium layer morphology,
abnormal nitric oxide homeostasis,
abnormal osteoclast differentiation,
abnormal osteoclast morphology,
abnormal osteoclast physiology,
abnormal pancreatic islet morphology,
abnormal peripheral nervous system regeneration,
abnormal physiological neovascularization,
abnormal renal glomerulus morphology,
abnormal respiratory bronchiole morphology,
abnormal response to infection,
abnormal response to tactile stimuli,
abnormal sensory capabilities/reflexes/nociception,
abnormal sleep pattern,
abnormal surfactant physiology,
abnormal systemic arterial blood pressure,
abnormal thermal nociception,
abnormal tooth hard tissue morphology,
abnormal tumor susceptibility,
abnormal uterine artery morphology,
abnormal uterus morphology,
abnormal vitreous body morphology,
behavior/neurological phenotype,
cardiovascular system phenotype,
decreased cerebral infarct size,
decreased circulating alanine transaminase level,
decreased circulating aspartate transaminase level,
decreased digestive secretion,
decreased eosinophil cell number,
decreased litter size,
decreased liver glycogen level,
decreased oligodendrocyte number,
decreased osteoclast cell number,
decreased pancreatic beta cell mass,
decreased survivor rate,
decreased susceptibility to endotoxin shock,
decreased susceptibility to induced choroidal neovascularization,
decreased susceptibility to induced colitis,
decreased susceptibility to injury,
decreased susceptibility to kidney reperfusion injury,
decreased systemic arterial systolic blood pressure,
decreased urine prostaglandin level,
decreased white adipose tissue amount,
delayed wound healing,
enhanced central nervous system regeneration,
enhanced wound healing,
enlarged inguinal lymph nodes,
enlarged seminiferous tubules,
homeostasis/metabolism phenotype,
hyperlactation,
immune system phenotype,
improved glucose tolerance,
increased IgG2a level,
increased T cell proliferation,
increased bone volume,
increased circulating VLDL triglyceride level,
increased circulating antidiuretic hormone level,
increased circulating creatinine level,
increased circulating ketone body level,
increased circulating prolactin level,
increased compact bone mass,
increased food intake,
increased growth rate,
increased insulin sensitivity,
increased interferon-gamma secretion,
increased kidney weight,
increased left ventricle developed pressure,
increased length of allograft survival,
increased liver triglyceride level,
increased mean systemic arterial blood pressure,
increased mortality induced by ionizing radiation,
increased myocardial infarct size,
increased renin activity,
increased sensitivity to induced morbidity/mortality,
increased single-positive T cell number,
increased sperm number,
increased susceptibility to experimental autoimmune encephalomyelitis,
increased susceptibility to parasitic infection,
increased susceptibility to pharmacologically induced seizures,
increased systemic arterial blood pressure,
increased systemic arterial systolic blood pressure,
increased testis weight,
increased triglyceride level,
increased urine pH,
nervous system phenotype,
neuron degeneration,
premature death,
prolonged diestrus,
reproductive system phenotype,
respiratory system phenotype
[+]
|